| Literature DB >> 35144751 |
Karim Taha1, Feddo P Kirkels2, Arco J Teske3, Folkert W Asselbergs4, J Peter van Tintelen5, Pieter A Doevendans6, Shelby Kutty7, Kristina H Haugaa8, Maarten J Cramer9.
Abstract
Clinical screening of the relatives of patients with genetic cardiomyopathies is challenging, as they often lack detectable cardiac abnormalities at presentation. Life-threatening adverse events can already occur in these early stages of disease, so sensitive tools to reveal the earliest signs of disease are needed. The utility of echocardiographic deformation imaging for early detection has been explored for this population in multiple studies but has not been broadly implemented in clinical practice. The authors discuss contemporary evidence on the utility of deformation imaging in relatives of patients with genetic cardiomyopathies. The available body of data shows that deformation imaging reveals early disease-specific abnormalities in dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy. Deformation imaging seems promising to enhance the screening and follow-up protocols in relatives, and the authors propose measures to accelerate its implementation in clinical care.Entities:
Keywords: deformation imaging; early detection; family screening; genetic cardiomyopathy; speckle tracking
Mesh:
Year: 2022 PMID: 35144751 DOI: 10.1016/j.jacc.2021.11.045
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094